Cargando…

State-of-the-Art Treatments for Sarcoidosis

Sarcoidosis is a heterogeneous disease with various treatment indications. Although it affects mainly the lungs, sarcoidosis can affect every organ, especially when the disease course is chronic and protracted. Regular patient follow-up is recommended for early recognition of active, ongoing organ-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Papanikolaou, Ilias C., Antonakis, Emmanouil, Pandi, Aggeliki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Houston Methodist DeBakey Heart & Vascular Center 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237819/
https://www.ncbi.nlm.nih.gov/pubmed/35772032
http://dx.doi.org/10.14797/mdcvj.1068
_version_ 1784736887386144768
author Papanikolaou, Ilias C.
Antonakis, Emmanouil
Pandi, Aggeliki
author_facet Papanikolaou, Ilias C.
Antonakis, Emmanouil
Pandi, Aggeliki
author_sort Papanikolaou, Ilias C.
collection PubMed
description Sarcoidosis is a heterogeneous disease with various treatment indications. Although it affects mainly the lungs, sarcoidosis can affect every organ, especially when the disease course is chronic and protracted. Regular patient follow-up is recommended for early recognition of active, ongoing organ-specific granulomatous inflammation to avoid progression to irreversible fibrosis. In this review, we elaborate on treatment indications and various anti-sarcoidosis regimens proven useful in clinical trials. We also review specialized treatment of specific disease manifestations, with a focus on cardiac sarcoidosis. We also report on treatment for special conditions such as fatigue and small fiber neuropathy. Treatment for sarcoidosis is an emerging landscape, with new data complementing the existing knowledge.
format Online
Article
Text
id pubmed-9237819
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Houston Methodist DeBakey Heart & Vascular Center
record_format MEDLINE/PubMed
spelling pubmed-92378192022-06-29 State-of-the-Art Treatments for Sarcoidosis Papanikolaou, Ilias C. Antonakis, Emmanouil Pandi, Aggeliki Methodist Debakey Cardiovasc J Review Sarcoidosis is a heterogeneous disease with various treatment indications. Although it affects mainly the lungs, sarcoidosis can affect every organ, especially when the disease course is chronic and protracted. Regular patient follow-up is recommended for early recognition of active, ongoing organ-specific granulomatous inflammation to avoid progression to irreversible fibrosis. In this review, we elaborate on treatment indications and various anti-sarcoidosis regimens proven useful in clinical trials. We also review specialized treatment of specific disease manifestations, with a focus on cardiac sarcoidosis. We also report on treatment for special conditions such as fatigue and small fiber neuropathy. Treatment for sarcoidosis is an emerging landscape, with new data complementing the existing knowledge. Houston Methodist DeBakey Heart & Vascular Center 2022-03-14 /pmc/articles/PMC9237819/ /pubmed/35772032 http://dx.doi.org/10.14797/mdcvj.1068 Text en Copyright: © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. See http://creativecommons.org/licenses/by/4.0/.
spellingShingle Review
Papanikolaou, Ilias C.
Antonakis, Emmanouil
Pandi, Aggeliki
State-of-the-Art Treatments for Sarcoidosis
title State-of-the-Art Treatments for Sarcoidosis
title_full State-of-the-Art Treatments for Sarcoidosis
title_fullStr State-of-the-Art Treatments for Sarcoidosis
title_full_unstemmed State-of-the-Art Treatments for Sarcoidosis
title_short State-of-the-Art Treatments for Sarcoidosis
title_sort state-of-the-art treatments for sarcoidosis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237819/
https://www.ncbi.nlm.nih.gov/pubmed/35772032
http://dx.doi.org/10.14797/mdcvj.1068
work_keys_str_mv AT papanikolaouiliasc stateofthearttreatmentsforsarcoidosis
AT antonakisemmanouil stateofthearttreatmentsforsarcoidosis
AT pandiaggeliki stateofthearttreatmentsforsarcoidosis